Effect of #ACE #Inhibitor and #ARB Initiation on Organ Support–Free Days in #Patients Hospitalized With #COVID19
A Randomized Clinical Trial - JAMA: https://jamanetwork.com/journals/jama/fullarticle/2803515?guestAccessKey=4694d866-267a-4a5d-9bbb-54479425c945&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jama&utm_content=etoc&utm_term=041123
#ace #inhibitor #arb #patients #COVID19
#Structure-based #design of a #SARS-CoV-2 #Omicron-specific #inhibitor https://www.pnas.org/doi/abs/10.1073/pnas.2300360120?af=R
#structure #design #sars #omicron #inhibitor
Design of CD73 #inhibitor|s
Introduction of 3' alkynyl moiety led to drastically improved antitumor activity. E. B. Sjogren and colleagues from Calithera Biosciences described the synthesis of these orally available nucleoside analogues in the Journal of Medicinal #Chemistry.
#Research #Science #medchem #chemistry #inhibitor
Design of CD73 #inhibitor|s
Introduction of 3' alkynyl moiety led to drastically improved antitumor activity. E. B. Sjogren and colleagues from Calithera Biosciences described the synthesis of these orally available nucleoside analogues in the Journal of Medicinal #Chemistry.
#Research #Science #medchem #chemistry #inhibitor
#CUO246 from #Novartis is a promising DNA #gyrase/#topoisomerase IV dual #inhibitor active against Gram-positive and Gram-negative #bacteria.
https://journals.asm.org/doi/full/10.1128/aac.00921-22
#CUO246 #novartis #bacteria #gyrase #inhibitor